We found that Gelsolin and PRDX4 are linked together, whose levels are influenced as a prognostic and predictive biomarker in CRC tumor tissues with lymph node metastasis (LNM) stage IV. This evidence concerns the gene PRDX4 and colorectal carcinoma.